Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy
Background: Brain metastases (BM) cause relevant morbidity and mortality in cancer patients. The presence of cerebrovascular diseases can alter the tumor microenvironment, cellular proliferation and treatment resistance. However, it is largely unknown if the presence of distinct cerebrovascular risk...
Main Authors: | Seong Jeong, Soniya Poudyal, Sabine Klagges, Thomas Kuhnt, Kirsten Papsdorf, Peter Hambsch, Johannes Wach, Erdem Güresir, Franziska Nägler, Alexander Rühle, Nils H. Nicolay, Clemens Seidel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/19/4845 |
Similar Items
-
VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01) -
VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01) -
Radiotherapy for nonagenarians: the value of biological versus chronological age
by: Tanja Sprave, et al.
Published: (2020-05-01) -
Editorial: Serum uric acid, vascular aging, and endocrine comorbidities
by: Yijun Hu, et al.
Published: (2023-09-01) -
CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumianceva, et al.
Published: (2015-09-01)